These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26152130)

  • 1. Pharmacokinetics and safety of 3,4-diaminopyridine base in healthy Japanese volunteers.
    Ishida N; Kobayashi E; Kondo Y; Matsushita R; Komai K
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):674-80. PubMed ID: 26152130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.
    Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA
    Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and tissue distribution of 3,4-diaminopyridine in rats.
    Ishida N; Kondo Y; Chikano Y; Kobayashi-Nakade E; Suga Y; Ishizaki J; Komai K; Matsushita R
    Biopharm Drug Dispos; 2019 Sep; 40(8):294-301. PubMed ID: 31419315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacokinetics/Pharmacodynamics of 3,4-Diaminopyridine Free Base in Patients With Lambert-Eaton Myasthenia.
    Thakkar N; Guptill JT; Aleš K; Jacobus D; Jacobus L; Peloquin C; Cohen-Wolkowiez M; Gonzalez D;
    CPT Pharmacometrics Syst Pharmacol; 2017 Sep; 6(9):625-634. PubMed ID: 28623849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-Diaminopyridine (DAP) in the treatment of Lambert-Eaton myasthenic syndrome (LEMS).
    Sanders DB
    Ann N Y Acad Sci; 1998 May; 841():811-6. PubMed ID: 9668334
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular safety of anagrelide in healthy subjects: effects of caffeine and food intake on pharmacokinetics and adverse reactions.
    Martínez-Sellés M; Datino T; Figueiras-Graillet L; Gama JG; Jones C; Franklin R; Fernández-Avilés F
    Clin Drug Investig; 2013 Jan; 33(1):45-54. PubMed ID: 23184666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amifampridine for the Management of Lambert-Eaton Myasthenic Syndrome: A New Take on an Old Drug.
    Yoon CH; Owusu-Guha J; Smith A; Buschur P
    Ann Pharmacother; 2020 Jan; 54(1):56-63. PubMed ID: 31319693
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and clinical pharmacokinetics of nemonoxacin, a novel non-fluorinated quinolone, in healthy Chinese volunteers following single and multiple oral doses.
    Guo B; Wu X; Zhang Y; Shi Y; Yu J; Cao G; Zhang J
    Clin Drug Investig; 2012 Jul; 32(7):475-86. PubMed ID: 22650326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort study.
    Flet L; Polard E; Guillard O; Leray E; Allain H; Javaudin L; Edan G
    J Neurol; 2010 Jun; 257(6):937-46. PubMed ID: 20058019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and safety profile of desmopressin oral tablet formulations in healthy Chinese subjects under fasting and fed conditions.
    Li X; Zhang H; Zhu X; Li C; Chen H; Liu J; Chen G; Wu M; Liu C; Shen Z; Niu J; Liu B; Ding Y
    Int J Clin Pharmacol Ther; 2018 Sep; 56(9):434-442. PubMed ID: 30049304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of sugammadex 16 mg/kg in healthy Chinese volunteers.
    de Kam PJ; Hou J; Wang Z; Lin WH; van den Heuvel M
    Int J Clin Pharmacol Ther; 2015 Jun; 53(6):456-61. PubMed ID: 25907172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylator Status Impacts Amifampridine Phosphate (Firdapse™) Pharmacokinetics and Exposure to a Greater Extent Than Renal Function.
    Haroldsen PE; Sisic Z; Datt J; Musson DG; Ingenito G
    Clin Ther; 2017 Jul; 39(7):1360-1370. PubMed ID: 28641995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A retrospective study of the effects of 3,4-diaminopyridine treatment in Lambert-Eaton myasthenic syndrome].
    Naganuma R; Yabe I; Takahashi I; Matsushima M; Kano T; Sasaki H
    Rinsho Shinkeigaku; 2018 Feb; 58(2):83-87. PubMed ID: 29386498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome.
    Sanders DB; Massey JM; Sanders LL; Edwards LJ
    Neurology; 2000 Feb; 54(3):603-7. PubMed ID: 10680790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4-diaminopyridine as a treatment for amyotrophic lateral sclerosis.
    Aisen ML; Sevilla D; Gibson G; Kutt H; Blau A; Edelstein L; Hatch J; Blass J
    J Neurol Sci; 1995 Mar; 129(1):21-4. PubMed ID: 7751839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects.
    Hall J; Gillen M; Liu S; Miner JN; Valdez S; Shen Z; Lee C
    Drug Des Devel Ther; 2018; 12():1799-1807. PubMed ID: 29950814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and Safety of Posaconazole Administered by Intravenous Solution and Oral Tablet in Healthy Chinese Subjects and Effect of Food on Tablet Bioavailability.
    Li H; Wei Y; Zhang S; Xu L; Jiang J; Qiu Y; Mangin E; Zhao XM; Xie S
    Clin Drug Investig; 2019 Nov; 39(11):1109-1116. PubMed ID: 31432392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for eye movement disorders due to acquired brain injury.
    Rowe FJ; Hanna K; Evans JR; Noonan CP; Garcia-Finana M; Dodridge CS; Howard C; Jarvis KA; MacDiarmid SL; Maan T; North L; Rodgers H
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011290. PubMed ID: 29505103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind placebo-controlled study of 3,4-diaminopyridine in amytrophic lateral sclerosis patients on a rehabilitation unit.
    Aisen ML; Sevilla D; Edelstein L; Blass J
    J Neurol Sci; 1996 Jun; 138(1-2):93-6. PubMed ID: 8791245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.